WGS Form 4: CFO Settles 7,197 RSUs; Sells 3,728 Shares to Cover Taxes
Rhea-AI Filing Summary
GeneDx Holdings Corp. (WGS) Form 4 shows Chief Financial Officer Kevin Feeley reported transactions on 09/16/2025 related to the vesting and settlement of restricted stock units (RSUs). 7,197 RSUs were treated as vested and settled for no cash consideration, and the Reporting Person triggered a sell-to-cover transaction that sold 3,728 shares at a weighted average price of $121.4727 to satisfy tax withholding. After these transactions, Mr. Feeley directly beneficially owned 8,755 shares of Class A common stock.
In addition to direct holdings, the filing discloses contingent rights to receive 124,633 RSU shares and options to purchase 27,152 shares, which vest over time per their terms. The sale is described as non-discretionary and solely to cover withholding obligations.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine sell-to-cover after RSU settlement; minimal immediate market impact.
The filing documents a standard post-vesting mechanics where 7,197 RSUs settled and a portion of resulting shares (3,728) were sold to cover taxes at a weighted average price of $121.4727. Such transactions typically reflect tax obligations rather than a change in conviction by management. The Reporting Person retains direct ownership of 8,755 shares and significant unvested equity (RSUs for 124,633 shares and options for 27,152 shares), indicating ongoing alignment with shareholder value through equity incentives.
TL;DR: Disclosure aligns with Section 16 rules; no governance concerns flagged.
The Form 4 properly discloses the deemed settlement date (09/16/2025), the nature of the RSUs, and that the sale was to cover withholding obligations and not a discretionary sale. The filer indicates willingness to provide price-by-price details for the block trade upon request, which supports transparency. Retained unvested awards suggest continued employment-linked incentives rather than immediate divestiture.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 7,197 | $0.00 | -- |
| Exercise | Class A Common Stock | 7,197 | $0.00 | -- |
| Sale | Class A Common Stock | 3,728 | $121.4727 | $453K |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $118.28 to $123.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 with regard to the block trade. Following the reported sales, in addition to the 8,755 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 27,152 shares of Class A common stock, which RSUs and options vest according to their respective terms. 6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
